Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Virchows Arch. 2012 Aug;461(2):221-5. doi: 10.1007/s00428-012-1266-3. Epub 2012 Jul 3.
Primary hypothyroidism causes adenohypophysial hyperplasia via stimulation by hypothalamic thyrotropin-releasing hormone (TRH). The effect was long thought to simply result in thyroid-stimulating hormone (TSH) and prolactin (PRL) cell hyperplasia, an increase in TSH and PRL blood levels with resultant pituitary enlargement, often mimicking adenoma. Recently, it was shown that transformation of growth hormone (GH) cells into TSH cells takes place in both clinical and experimental primary hypothyroidism. Such shifts from one cell to another with a concomitant change in hormone production are termed "transdifferentiation" and involve the gradual acquisition of morphologic features of thyrotrophs ("somatothyrotrophs"). We recently encountered a unique case of pituitary hyperplasia in a 40-year-old female with primary hypothyroidism wherein increased TSH production was by way of PRL cell recruitment. The resultant "lactothyrotrophs" maintained TSH cell morphology (cellular elongation and prominence of PAS-positive lysosomes) but expressed immunoreactivity for both hormones. No co-expression of GH was noted nor was thyroidectomy cells seen. This form of transdifferentiation has not previously been described.
原发性甲状腺功能减退症通过下丘脑促甲状腺激素释放激素 (TRH) 的刺激引起腺垂体增生。长期以来,人们认为这种作用仅仅导致促甲状腺激素 (TSH) 和催乳素 (PRL) 细胞增生,即 TSH 和 PRL 血液水平升高,导致垂体增大,常类似于腺瘤。最近,人们发现临床和实验性原发性甲状腺功能减退症中都发生了生长激素 (GH) 细胞向 TSH 细胞的转化。这种从一种细胞到另一种细胞的转变,同时伴随着激素产生的变化,被称为“转分化”,涉及到逐渐获得促甲状腺细胞的形态特征(“体促甲状腺细胞”)。我们最近在一名 40 岁女性的原发性甲状腺功能减退症中遇到了一个独特的垂体增生病例,其中 TSH 的产生增加是通过催乳素细胞募集而来的。由此产生的“催乳素促甲状腺细胞”保持了 TSH 细胞的形态(细胞伸长和 PAS 阳性溶酶体突出),但表达了两种激素的免疫反应性。没有注意到 GH 的共表达,也没有看到甲状腺切除术细胞。这种形式的转分化以前没有被描述过。